I am working with SH-SY5Y cells transfected with α-synuclein and I am studying the effects of glutamine on Parkinson's Disease progression. Since the cells are already transfected with the SNCA gene (α-synuclein), it is not possible to transfect them with a new plasmid. I would like to study ATF4's effects on PD progression, but since I cannot upregulate the ATF4 gene in the cells, I was wondering if I could just add the recombinant transcription factor onto the cells.

Thank you!

More Rohit Mantena's questions See All
Similar questions and discussions